NeoGenomics Reports that its NeoLAB® Liquid Biopsy Prostate Test is More Accurate than Conventional Biopsies in Predicting High Grade Prostate Cancer
Press Release
Read More
NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017
Press Release
Read More
NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development
Press Release
Read More
Wild-type blocking PCR combined with direct sequencing as a highly sensitive method for detection of low-frequency somatic mutations
Literature
Read More
Correlation Between MET Gene Amplification and TP53 Mutation in Upregulating PD-L1 Expression in EGFR-Wild-Type Lung Cancer
Literature
Read More
NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing
Press Release
Read More